News & Updates

Show Multimedia Only

Vitamin D, calcium supplementation does little to improve bone mass in teens

13 Feb 2026 by

For adolescents with perinatally acquired HIV, supplementation with vitamin D3 and calcium appears to have limited benefit in terms of promoting bone accrual and mineralization, as shown in the phase III VITALITY study.

Vitamin D, calcium supplementation does little to improve bone mass in teens

13 Feb 2026

Hypertensive disorders of pregnancy linked to LV remodelling

13 Feb 2026

An association exists between hypertensive disorders of pregnancy (HDP) and adverse left ventricular (LV) remodelling, which is partially mediated by post-pregnancy BMI, suggests a study.

Hypertensive disorders of pregnancy linked to LV remodelling

13 Feb 2026

Mirikizumab improves IBD outcomes during induction, maintenance periods

13 Feb 2026 by

Treatment with mirikizumab results in significant improvements in clinical, endoscopic, and histologic outcomes during induction and maintenance phases in patients with Crohn’s disease (CD) or ulcerative colitis (UC), according to an updated meta-analysis of randomized controlled trials (RCTs).

Mirikizumab improves IBD outcomes during induction, maintenance periods

13 Feb 2026

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

13 Feb 2026 by

Treatment with either vedolizumab or ustekinumab delivers significant and meaningful benefits to patients with Crohn’s disease (CD), but each has its distinct therapeutic profile with complementary advantages, reports a real-world study presented at CCC 2026.

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

13 Feb 2026

Drinking water salinity may affect BP levels

13 Feb 2026 by

A systematic review and meta-analysis show an association between elevated salinity in drinking water and higher systolic blood pressure (SBP) and diastolic BP (DBP) levels, particularly among individuals residing in coastal areas.

Drinking water salinity may affect BP levels

13 Feb 2026

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

13 Feb 2026 by

A 67-year-old man was diagnosed with polycythaemia vera (PV) in 2005. Over the next several years, he received various cytoreductive agents, including anagrelide, pegylated interferon (IFN) and hydroxyurea.

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

13 Feb 2026

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

13 Feb 2026

Peppermint oil or peppermint sweets appear to do little in terms of relieving pain in children with irritable bowel syndrome (IBS) or functional abdominal pain–not otherwise specified, as shown in a study.

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

13 Feb 2026

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

13 Feb 2026 by

The use of intra-arterial (IA) alteplase following a successful endovascular thrombectomy (EVT) improves 90-day functional outcome in patients with large-vessel occlusion (LVO) acute ischaemic stroke compared with EVT-alone, according to the CHOICE 2* trial presented at ISC 2026.

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

13 Feb 2026

mOS of nearly 4 years in Tx-naïve BRAFV600E-mutant mNSCLC with combination therapy newly available in HK

13 Feb 2026

Updated results of the phase II PHAROS study of encorafenib plus binimetinib, a BRAF plus MEK inhibitor combination that has recently become available in Hong Kong, include a median overall survival (mOS) of 47.6 months in treatment-naïve patients and 22.7 months in previously treated patients with BRAF^V600E-mutant metastatic non-small-cell lung cancer (mNSCLC).

mOS of nearly 4 years in Tx-naïve BRAFV600E-mutant mNSCLC with combination therapy newly available in HK

13 Feb 2026

Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2

13 Feb 2026 by

A single intranasal dose of a live-attenuated broad-spectrum coronavirus vaccine developed at the University of Hong Kong (HKU) elicits broad, potent and long-lasting immunity against diverse SARS-CoV-2 variants of concern (VoCs) and more divergent SARS-CoV-1 and hCoV-OC43 that translates into complete protection in animal models, including prevention of viral transmission to unvaccinated contacts.

Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2

13 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Vitamin D, calcium supplementation does little to improve bone mass in teens

Vitamin D, calcium supplementation does little to improve bone mass in teens

Hypertensive disorders of pregnancy linked to LV remodelling

Hypertensive disorders of pregnancy linked to LV remodelling

Mirikizumab improves IBD outcomes during induction, maintenance periods

Mirikizumab improves IBD outcomes during induction, maintenance periods

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

Drinking water salinity may affect BP levels

Drinking water salinity may affect BP levels

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

mOS of nearly 4 years in Tx-naïve BRAFV600E-mutant mNSCLC with combination therapy newly available in HK

mOS of nearly 4 years in Tx-naïve BRAFV600E-mutant mNSCLC with combination therapy newly available in HK

Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2

Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2